Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

MCD Haematology > Haemostasis > Flashcards

Haemostasis Flashcards

1
Q

what is the haemostatic response to endothelial injury [4]

A
  • vessel constriction
  • formation of unstable platelet plug
  • stabilisation of plug with fibrin
  • dissolution of clot and vessel repair
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what occurs with platelets in unstable plug formation?

A

adhesion and aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the function the endothelium?

A
  • Maintain barrier between blood and tissue factor.

- Synthesis of PGI2, thrombomodulin, vWF, plasminogen activators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the platelet transformation process from stem cell to release from the bone marrow?

A

origin: bone marrow

  • haemopoietic stem cell precursors
  • myeloid stem cell
  • megakaryocytes precursor
  • undergoes nuclear replication without cytoplasmic division
  • matures and granulate
  • migrates to marrow sinusoids
  • megakaryocytes produce ~4000 platelets by fragmenting into circulation through the endothelial wall of the bone marrow
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the lifespan of a platelet?

A

~10 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

how much platelets is stored/sequestered in the spleen?

A

1/3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

platelet features

what are the glycopeptides on the surface?

A

Dense granules
alpha-granules
thrombin receptors
surface glycoproteins: Glp1a, Glp1b, Glp2b/3a).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what glycoprotein of a platelet does vWF bind to?

A

Glp1b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what does Glp1a bind to?

A

collagen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what needs to be released to cause enhanced aggregation?

what is the effect?

A

ADP (released from platelets granules) and thromboxane from other platelets

causes Glp2b/3a receptor expression on the platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what do endothelial cells and platelets produce mainly

A

endothelial- PGI2 (prostacyclin)

platelets- TXA2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what enzyme makes the final PGI2 product?

A

prostacyclin synthetase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what enzymes makes the final TXA2 product?

A

thromboxane synthetase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what effect that PGI2 have on platelets?

A

potent inhibitor of platelet function

remember prostacyclin is anti-thrombotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the effects of endoperoxides (PGG2 and PGH2) and thromboxanes on platelets?

A

potent inducer of aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what enzyme does aspirin affect in prostaglandin metabolism?

A

cyclo oxygenase (COX1)

[converts arachidonic acid to endoperoxides]

prevents TXA2 production so it can’t activate platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

examples of COX1 inhibitors

A

aspirin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

examples of ADP receptor antagonists

A

clopidogrel (P2Y12)

prasugrel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

example of Glp2b,3a antagonists

A

Abciximab
Tirofiban,
Eptifibatide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

drug classes used in antithrombotic therapy in the ARTERIAL system?

A

 COX-1 Inhibitors/antagonists
 ADP receptor antagonists
 GlpIIb/IIIa antagonists

i.e. antiplatelets

blood is too fast for coagulation due to stasis to happen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

examples of lab tests

A

platelet count (monitor thrombocytopenia)

bleeding time and platelet aggression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what does ITP present with

A

Auto-immune Thrombocytopenia (ITP) presents with – purpura, multiple bruises, ecchymoses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

example of when platelet count would be used in monitoring treatment?

A

In treatment of leukaemia’s, you can knock out platelets.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what does bleeding time reveal?

A

check platelet-vessel-wall interactions, when the platelet count is normal, e.g. renal disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

what does platelet aggregation reveal?

A

measures functional defect of platelets, e.g. vWF disease, inherited defects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

what are the sites of clotting factor, fibrinolytic factor and inhibitor synthesis?

A
  • liver (coag.proteins, antithrombin)
  • endothelial cells (VWF)
  • megakaryocytes (VWF, Factor V)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

order of factors in intrinsic pathway until thrombin formation

A

12,11,9, 10

28
Q

where does TF get involved?

A

in the extrinsic pathway with F7

29
Q

what is tested for to show the intrinsic pathway

A

F12

30
Q

what factors drive the positive feedback loop from the intrinsic pathway into the common pathway?

A

8a (for 9a) and 5a (for 10a)

phospholipids found on platelet surface membrane

31
Q

what does F9a activate?

via which factor?

A

F10 via F8aPI

32
Q

what does F10a activate?

via which factor?

A

F2 (prothrombin to thrombin) via F5aPI

33
Q

what is the effect of thrombin apart from fibrin formation?

A
  • drive more platelet activation
  • more expression of F8a and F5a PIs
    thrombin generation is accelerated by x10000 by F8a and F5a PI
34
Q

which vitamin mediates the production of factor 2, 7, 9, 10?

where is this done?
what extra group do these factors have?

A

Vitamin K

in the liver

extra carboxyl group

35
Q

what is the effect of the extra carboxyl group on the factors?

A

allow adherence to the platelet membranes phospholipids

36
Q

what is the extra carboxyl unit on the factors?

A

gamma-carboxyglutamic acid

37
Q

what enzyme does warfarin inhibit?

what is the effect of this?

A

vitamin K epoxide reductase

reduced secretion of clotting factors and their binding e.g. f10

interactions to membrane PL is reduced as they can’t bind with Ca2+

38
Q

what is the indication for warfarin?

A

long-term anticoagulation following venous thrombosis
treatment of atrial fibrillation
stroke prophylaxis
DVT treatment

39
Q

what is the effect of Heparin?

A

binds to antithrombin and speeds it up 3000x

40
Q

what is the indication for heparin?

A

immediate/ acute anticoagulation in peripheral oedema and DVT
MI
unstable angina
pulmonary embolism

41
Q

what factors does antithrombin affect?

A

F11a, F10a, F9a, F2a(thrombin)

42
Q

how does antithrombin have its anticoagulation effect

A

binds to factors irreversibly by altering their tertiary structure e.g. bind to active site
[9a, 10a, 2a]

43
Q

structure of heparin

A

negatively charged string-like structure

44
Q

what are the forms of heparin that can be used?

when are they used

A

1) low MW
2) high MW

both can be used to inhibit F10a

only high MW can be used to inhibit F2a (thrombin) as It anchors the antithrombin to it better

45
Q

which lab test detects abnormality in the intrinsic (and common) pathways?

how does it do this?

A

Activated Partial Thromboplastin Time (APTT)

  • initiates coag. via F12
46
Q

what lab test detects abnormality in the extrinsic (and common) pathways?

how does it do this?

A

Prothrombin Time (PT)

  • initiates coag. via TF
47
Q

what lab test detects abnormality in fibrinogens conversion to fibrin?

A

Thrombin Clotting Time (TCT/TT)

  • add thrombin (activated thrombin facilitates the conversion)
48
Q

what tests are used to detect bleeding disorders?

A

APTT

PT

49
Q

what test is used to monitor heparin therapy in thrombosis?

A

APTT as intrinsic pathway needs to be monitored

50
Q

what test is used to monitor warfarin therapy in thromboses?

A

PT as extrinsic pathway and common pathway need to be monitored

51
Q

what is required for the production of plasmin from plasminogen?

A

Tissue Plasminogen Activator (TPA) and a fibrin clot

without the clot, the plasminogen (zymogen) does not interact to create plasmin

52
Q

what is the role of plasmin?

A

fibrin degradation (fibrinolysis)

activated from plasminogen by tPA

53
Q

what components of fibrinolysis are used therapeutically for thrombolysis in MI?

A

TPA (alteplase)

bacterial activator streptokinase

54
Q

what factors are inhibited by antithrombin in the coag. inhibition mechanism?

A

F9a
F10a
F2a (thrombin)

55
Q

what factors are inhibited by Protein S and C in the coag. inhibition mechanism?

A

F8a and F5a

56
Q

how is protein S and C activated?

A

when thrombin binds to platelets to create thrombomodulin which then activates protein S and C

57
Q

how does the prothrombin time change in haemophilia?

A

prolonged

i.e. clotting time has increased

58
Q

which factors does the anticoagulants warfarin inhibit the activation of?

A

2,7,9,10

all them key players

59
Q

why is prothrombin time used to measure the effect of warfarin?

A

warfarin impacts factor 7
factor 7 is part of the extrinsic pathway involving tissue factor

the tissue factor/extrinsic pathway is best measured using prothrombin time

60
Q

how are the effects of heparin measured?

A

using activated partial thromboplastin time (APTT)

  • intrinsic pathway and common pathway measurement
  • heparin enhances the actions antithrombin (an enzyme inhibitor glycoprotein produced in the liver)
  • antithrombin can deactivate thrombin, f10 etc
61
Q

what are 3 examples of antiplatelets?

A

1) aspirin–> COX-1 therefore TXA2 reduced
2) clopidogrel–> ADP receptor
3) tirofiban–> GlpIIb/IIIa inhibitor

in acute management of MI

nb warfarin and heparin are antiCOAGULANTS (efficacy in secondary haemostasis)

62
Q

what is the role of TXA2?

A

expression of GlpIIb/IIIa

released by platelet activation

63
Q

what is the function of the haemostatic plug?

A

prevent blood loss from intact vessels

arrest bleeding from injured vessels

64
Q

what is the first response to injury?

A

vessel constriction

temporarily restrict blood loss

65
Q

what molecules activate platelets leading to formation of unstable plug?

A

ADP
thrombin
TXA2 (made from membrane phospholipids)

66
Q

how is the unstable plug stabilised?

A

by coagulation (initiated by Tissue Factor)

this produces the fibrin clot

67
Q

what vessels disorders arise due to impaired interaction of platelets with the injured vessels?

A
  • scurvy
  • senile purpura
  • allergic vasculitis (acquired)
  • haemorrhagic telangiectasia
  • Ehlers-Danlos syndrome (inherited).

MCD Haematology (11 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions